Document is current
Any future updates will be listed below
-
Authors
Karasic, Thomas B. https://orcid.org/0000-0001-9157-5392
Chiorean, E. Gabriela
Sebti, Said M.
O’Dwyer, Peter J.
-
Funding
Funding for this research was provided by:
Tigris Pharmaceuticals
- License Information
-
More Information
Article History
First Online: 1 August 2019
Compliance with Ethical Standards
:
: This study was funded by Tigris Pharmaceuticals.
: Said Sebti is co-inventor of GGTI-2418 and chief scientific officer of Prescient Therapeutics, the manufacturer of GGTI-2418. Thomas Karasic declares that he has no conflict of interest. E. Gabriela Chiorean declares that she has no conflict of interest. Peter O’Dwyer declares that he has no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
